Thirdly, and as explained in some detail by Fan et al. [24], the feasibility, and inherent practicality of analysing LRRK2 and Rab10 phosphorylation in peripheral (non-CNS) cells, exemplified by the readily isolated neutrophil subpopulation, could lead to changes in PD patient sampling protocols. This evidence concerns the gene RAB10 and Parkinson disease.